Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00076323 · ClinicalTrials.gov registry record · NA
A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency
A NA study, sponsored by Walter Reed Army Institute of Research (WRAIR).
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT00076323: Completed NA study, sponsored by Walter Reed Army Institute of Research (WRAIR).
NCT00076323 is a NA study that has completed, run by Walter Reed Army Institute of Research (WRAIR). The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00076323, a NA study, has completed, sponsored by Walter Reed Army Institute of Research (WRAIR).
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
Interventions
- DRUG Primaquine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2003-12 |
| Est. Completion | 2006-11 |
| Phase | NA |
What the finished NCT00076323 record still lists
NCT00076323 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Primaquine is the first listed.
NCT00076323 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00076323 about?
NCT00076323 is a clinical study titled "A Test to Predict the Hemolytic Potential of Drugs in G6PD Deficiency". This study will evaluate a new and safe testing method for identifying medicines that can cause problems in glucose-6-phosphate dehydrogenase (G6PD) deficient individuals. We are looking for volunteers with G6PD deficiency who would be willing to donate blood samples.
What is the current status of trial NCT00076323?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2003-12. Estimated completion is 2006-11.
What interventions are being tested in trial NCT00076323?
The interventions under investigation include: Primaquine (DRUG).
Who is sponsoring clinical trial NCT00076323?
This trial is sponsored by Walter Reed Army Institute of Research (WRAIR), which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00076323's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia